Navigation Links
Study shows epigenetic changes in children with Crohn's disease
Date:8/22/2014

August 22, 2014 A new study finds a wide range of epigenetic changesalterations in DNA across the genome that may be related to key environmental exposuresin children with Crohn's disease (CD), reports Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America (CCFA). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

The study provides "compelling evidence" of alterations of DNA in several regions of the genome in children with CD, according to Professor Jack Satsangi of University of Edinburgh and colleagues. In addition to providing new insights into how genes and the environment interact, the results may have early implications for clinical management of CD.

Epigenetic Changes in Childhood-Onset Crohn's Disease

The researchers performed a "genome-wide" study in children with newly diagnosed CD, before any treatment, to look for possible epigenetic changes that may affect gene behavior. Epigenetic changes reflect the impact of a wide range of environmental factors on genes.

The results showed strong evidence of such changes at 65 different sites across the genome. Nineteen sites showed clustering of epigenetic changes, pointing at genetic pathways that might be relevant to CD development.

Similar patterns were present in a separate group of children who had been treated for CD, as well as in a group of treated adults.

The study highlighted "highly significant" changes in two specific gene locations (loci), which include genes responsible for immune and cellular functions that could contribute to the development of CD. Two probes for these loci were highly accurate in predicting which children would have CD, providing a potentially useful "biomarker" for use as a diagnostic test.

'Exciting and Immediate Implications' for Clinical Management

One specific gene location seemed particularly important, as it has been implicated in a number of different cancers, including colorectal cancer. The same area has a known role in the development of T-cells, a key type of immune cell.

The study also identified a number of other loci that might play a role in the development of CD, warranting further study.

The new research adds to the growing body of evidence of epigenetic changes in diseases such as rheumatoid arthritis, multiple sclerosis, type 2 diabetes, and obesity. The findings highlight the importance of combining information on DNA changes, genes, and gene expression in future studies of these and other complex diseases, Dr Satsangi and colleagues believe.

Crohn's disease is a painful, medically incurable illness that may attack anywhere along the digestive system. Crohn's disease and ulcerative colitis, which involves only the large intestine (colon), are the two main types of inflammatory bowel disease. Some 1.4 million American adults and children suffer from CD or ulcerative colitis.

Although much more research is needed to understand the epigenetic changes, the investigators believe their findings could lead to advances in clinical management of childhood-onset CD in the near future. They write, "There are exciting and immediate implications for early clinical translation; the discovery of easily accessible biomarkers in peripheral blood to predict disease susceptibility, progression or response to therapy and the potential for new therapeutic targets."


'/>"/>
Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health
Source:Eurekalert

Related medicine news :

1. Study identifies challenges faced by NYU nurses after Hurricane Sandy
2. Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests
3. New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade
4. Dr. Mary Hayes: Study Shows 3D Mammography Finds More Invasive Cancers While Reducing Unnecessary Recalls
5. Fewer U.S. Teens Using Sunscreen, Study Finds
6. Difficulty assessing effort drives motivation deficits in schizophrenia, study finds
7. Study: Men, Lesbians More Likely to Have Orgasms
8. Kids With Autism Have Extra Brain Connections, Study Says
9. Study shows steep decline in tooth loss, increase in socioeconomic disparities
10. Study Finds Bacteria Compound Shrinks Mesothelioma Tumors, According to Surviving Mesothelioma
11. Study Suggests Environmental Factors May Outweigh Genetics When It Comes to Myopia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate ... the electrifying line-up of events for its annual meeting “Coming Home 2017,” an ... “Coming Home 2017” will be held on Friday January 27 through Sunday, ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
(Date:1/20/2017)... ... 2017 , ... Source Vitál Apothecary, a skin and body care company dedicated ... company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports Nutrition ... in the nutritional, sports and health industries a chance to meet in private sessions ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... ... and wellness products to enhance people’s everyday lives, recently attended the January ECRM ... buyers. , ATP Science is known for its large range of supplements that ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has launched ... The drinks have been produced in collaboration with Zlatan Ibrahimovic and have been ... , After a successful launch in Sweden last year, the next generation sports ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
Breaking Medicine Technology: